Hepatic arterial infusion chemotherapy using high-dose 5-fluorouracil and cisplatin with or without interferon-α for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis

Jong Ryul Eun, Heon Ju Lee, Hee Jung Moon, Tae Nyeun Kim, Jae Woon Kim, Jay Chun Chang

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Abstract

Objective. In this retrospective study, we assessed the efficacy of hepatic arterial infusion chemotherapy (HAIC) using high-dose 5-fluorouracil (5-FU) and cisplatin with or without interferon (IFN)-α for the treatment of advanced hepatocellular carcinoma (HCC) with portal vein tumor thrombosis. Material and methods. Fifty-two patients were included in the analysis. The patients were treated with 5-FU (750 mg/m2) and cisplatin (25 mg/m2) from Days 1 to 4. IFN-α was administered subcutaneously at a dose of 3 million units from Days 1 to 4, and then every other day for 24 days. Chemotherapy was repeated every 4 weeks. Thirty-one patients were treated with 5-FU, cisplatin and IFN-α (FPI group) and 21 were treated with 5-FU and cisplatin (FP group). Results. An objective tumor response was achieved in six patients (19.4%) in the FPI group. In the FP group, 12 patients (57.1%) achieved an objective tumor response (p = 0.015). The cumulative survival rate was higher in the FP group than the FPI group, but this difference was not statistically significant (p = 0.353). The median survival time for the 18 responders was 14 months (range 4=25 months), and their 6, 12, and 24-month cumulative survival rates were 89%, 83%, and 25%, respectively. Conclusions. HAIC using high-dose 5-FU plus cisplatin achieved a good tumor response. Adding IFN-α did not show any additional beneficial effects in terms of tumor response rate or survival.

Original languageEnglish
Pages (from-to)1477-1486
Number of pages10
JournalScandinavian Journal of Gastroenterology
Volume44
Issue number12
DOIs
StatePublished - 29 Dec 2009

Keywords

  • 5-fluorouracil
  • Cisplatin
  • Hepatic arterial infusion chemotherapy
  • Hepatocellular carcinoma
  • Interferon-α

Fingerprint

Dive into the research topics of 'Hepatic arterial infusion chemotherapy using high-dose 5-fluorouracil and cisplatin with or without interferon-α for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis'. Together they form a unique fingerprint.

Cite this